| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 600380 from our risk checks.
Joincare Pharmaceutical Group Industry Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.53 |
| 52 Week High | CN¥13.25 |
| 52 Week Low | CN¥9.51 |
| Beta | 0.36 |
| 11 Month Change | -9.32% |
| 3 Month Change | -22.58% |
| 1 Year Change | -21.17% |
| 33 Year Change | -22.77% |
| 5 Year Change | -8.80% |
| Change since IPO | -11.34% |
Recent News & Updates
Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market
Aug 13
We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease
Jun 23Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being
May 31Recent updates
Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market
Aug 13We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease
Jun 23Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being
May 31Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings
Apr 09Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel
Mar 04Shareholder Returns
| 600380 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.2% | -2.9% | -2.1% |
| 1Y | -21.2% | -17.4% | -21.1% |
Return vs Industry: 600380 underperformed the CN Pharmaceuticals industry which returned -17.4% over the past year.
Return vs Market: 600380 matched the CN Market which returned -21.1% over the past year.
Price Volatility
| 600380 volatility | |
|---|---|
| 600380 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 600380's share price has been volatile over the past 3 months.
Volatility Over Time: 600380's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 14,365 | Xiong Yu | www.joincare.com |
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products.
Joincare Pharmaceutical Group Industry Co.,Ltd. Fundamentals Summary
| 600380 fundamental statistics | |
|---|---|
| Market cap | CN¥17.86b |
| Earnings (TTM) | CN¥1.40b |
| Revenue (TTM) | CN¥16.16b |
12.7x
P/E Ratio1.1x
P/S RatioIs 600380 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600380 income statement (TTM) | |
|---|---|
| Revenue | CN¥16.16b |
| Cost of Revenue | CN¥6.41b |
| Gross Profit | CN¥9.75b |
| Other Expenses | CN¥8.35b |
| Earnings | CN¥1.40b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Sep 20, 2024
| Earnings per share (EPS) | 0.75 |
| Gross Margin | 60.35% |
| Net Profit Margin | 8.69% |
| Debt/Equity Ratio | 21.5% |
How did 600380 perform over the long term?
See historical performance and comparison